SlideShare ist ein Scribd-Unternehmen logo
1 von 19
Pharmacist Lama Al.Homoud Director of Clinical Pharmacy Directorate / MOH MeTA Committee 1:   Encouraging best practice  & Improve Rational Use of Medicines
Committee Members ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Background ,[object Object]
Background ,[object Object],[object Object]
[object Object],[object Object],[object Object],Priority Areas in Jordan’s  MeTA Workplan
Scope of Work ,[object Object],[object Object],[object Object],[object Object]
Improve rational use of medicines ,[object Object],[object Object],[object Object],[object Object]
Strategy I:   Assessment and gap analysis ,[object Object],[object Object],[object Object]
Strategy I: Assessment and gap analysis ,[object Object],[object Object],[object Object],[object Object]
Strategy II:   Development and Implementation plan for the STG ,[object Object],[object Object],[object Object],[object Object]
Strategy III: Evaluation of a pilot area &  Multi-Sectoral dissemination ,[object Object],[object Object],[object Object],[object Object]
Work plan Sub-activities ,[object Object],[object Object],[object Object],[object Object],[object Object]
Work plan Sub-activities ,[object Object],[object Object],[object Object]
Performance Progress and Evaluation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Means of Verification Performance Indicators ,[object Object],[object Object],[object Object],[object Object],[object Object]
Expected outcomes ,[object Object],[object Object],[object Object]
National Institute for  Clinical Excellence  (NICE) ,[object Object],[object Object],[object Object]
National Institute for  Clinical Excellence  (NICE) ,[object Object],[object Object],[object Object]
Encouraging best practice and improve the rational  use of medicines

Weitere ähnliche Inhalte

Was ist angesagt?

Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel   collab formulary hospital-public plan - eric lun finalCadth 2015 c6 panel   collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun finalCADTH Symposium
 
Trudel Cms Rules 072810[1]
Trudel Cms Rules 072810[1]Trudel Cms Rules 072810[1]
Trudel Cms Rules 072810[1]nealkanage
 
HIT Standards Committee Trudel CMS Rules
HIT Standards Committee Trudel CMS RulesHIT Standards Committee Trudel CMS Rules
HIT Standards Committee Trudel CMS RulesBrian Ahier
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacyPrajith V
 
HTA training - Philip Watt, CF Ireland - July 26th 2016
HTA training - Philip Watt, CF Ireland - July 26th 2016HTA training - Philip Watt, CF Ireland - July 26th 2016
HTA training - Philip Watt, CF Ireland - July 26th 2016ipposi
 
Rational use of medicine
Rational use of medicineRational use of medicine
Rational use of medicineMuhammad Arsal
 
MeTA Assessment Toolbox
MeTA Assessment ToolboxMeTA Assessment Toolbox
MeTA Assessment ToolboxMeTApresents
 
HTA training - Jennifer Dickson, Scottich Medicines Consortium - July 26th 2016
HTA training - Jennifer Dickson, Scottich Medicines Consortium - July 26th 2016HTA training - Jennifer Dickson, Scottich Medicines Consortium - July 26th 2016
HTA training - Jennifer Dickson, Scottich Medicines Consortium - July 26th 2016ipposi
 
HTA Training - Prof Michael Barry - July 26th 2016
HTA Training - Prof Michael Barry - July 26th 2016HTA Training - Prof Michael Barry - July 26th 2016
HTA Training - Prof Michael Barry - July 26th 2016ipposi
 
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats inemet
 

Was ist angesagt? (15)

What Can You Do at the UNC Eshelman School of Pharmacy
What Can You Do at the UNC Eshelman School of PharmacyWhat Can You Do at the UNC Eshelman School of Pharmacy
What Can You Do at the UNC Eshelman School of Pharmacy
 
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel   collab formulary hospital-public plan - eric lun finalCadth 2015 c6 panel   collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
 
Trudel Cms Rules 072810[1]
Trudel Cms Rules 072810[1]Trudel Cms Rules 072810[1]
Trudel Cms Rules 072810[1]
 
HIT Standards Committee Trudel CMS Rules
HIT Standards Committee Trudel CMS RulesHIT Standards Committee Trudel CMS Rules
HIT Standards Committee Trudel CMS Rules
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
 
HTA training - Philip Watt, CF Ireland - July 26th 2016
HTA training - Philip Watt, CF Ireland - July 26th 2016HTA training - Philip Watt, CF Ireland - July 26th 2016
HTA training - Philip Watt, CF Ireland - July 26th 2016
 
Essential medicine
Essential medicine Essential medicine
Essential medicine
 
Rational use of medicine
Rational use of medicineRational use of medicine
Rational use of medicine
 
MeTA Assessment Toolbox
MeTA Assessment ToolboxMeTA Assessment Toolbox
MeTA Assessment Toolbox
 
Rational use of drug
Rational use of drugRational use of drug
Rational use of drug
 
HTA training - Jennifer Dickson, Scottich Medicines Consortium - July 26th 2016
HTA training - Jennifer Dickson, Scottich Medicines Consortium - July 26th 2016HTA training - Jennifer Dickson, Scottich Medicines Consortium - July 26th 2016
HTA training - Jennifer Dickson, Scottich Medicines Consortium - July 26th 2016
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
 
HTA Training - Prof Michael Barry - July 26th 2016
HTA Training - Prof Michael Barry - July 26th 2016HTA Training - Prof Michael Barry - July 26th 2016
HTA Training - Prof Michael Barry - July 26th 2016
 
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats
 
Due
DueDue
Due
 

Andere mochten auch

Evidence based decision making for the rational drug list (RDL)
Evidence based decision making for the rational drug list (RDL)Evidence based decision making for the rational drug list (RDL)
Evidence based decision making for the rational drug list (RDL)MeTApresents
 
MeTA Process and Progress in Jordan
MeTA Process and Progress in JordanMeTA Process and Progress in Jordan
MeTA Process and Progress in JordanMeTApresents
 
Drug hospital governance , pharmaceutical care, dose unit systems , ICT, inno...
Drug hospital governance , pharmaceutical care, dose unit systems , ICT, inno...Drug hospital governance , pharmaceutical care, dose unit systems , ICT, inno...
Drug hospital governance , pharmaceutical care, dose unit systems , ICT, inno...M. Luisetto Pharm.D.Spec. Pharmacology
 
Richiesta al miur dr. m.fidani dr. m. luisetto 2012 All right reserved , acce...
Richiesta al miur dr. m.fidani dr. m. luisetto 2012 All right reserved , acce...Richiesta al miur dr. m.fidani dr. m. luisetto 2012 All right reserved , acce...
Richiesta al miur dr. m.fidani dr. m. luisetto 2012 All right reserved , acce...M. Luisetto Pharm.D.Spec. Pharmacology
 
Clinical audit may 2011 nes pharmacy
Clinical audit  may 2011 nes pharmacyClinical audit  may 2011 nes pharmacy
Clinical audit may 2011 nes pharmacyNES
 
Legislation and regulation for best practices in pharmacy ra psn
Legislation and regulation for best practices in pharmacy ra psnLegislation and regulation for best practices in pharmacy ra psn
Legislation and regulation for best practices in pharmacy ra psnRemi ADESEUN
 
Food control agency and their roles
Food control agency and their rolesFood control agency and their roles
Food control agency and their rolesjyoti prakash
 

Andere mochten auch (7)

Evidence based decision making for the rational drug list (RDL)
Evidence based decision making for the rational drug list (RDL)Evidence based decision making for the rational drug list (RDL)
Evidence based decision making for the rational drug list (RDL)
 
MeTA Process and Progress in Jordan
MeTA Process and Progress in JordanMeTA Process and Progress in Jordan
MeTA Process and Progress in Jordan
 
Drug hospital governance , pharmaceutical care, dose unit systems , ICT, inno...
Drug hospital governance , pharmaceutical care, dose unit systems , ICT, inno...Drug hospital governance , pharmaceutical care, dose unit systems , ICT, inno...
Drug hospital governance , pharmaceutical care, dose unit systems , ICT, inno...
 
Richiesta al miur dr. m.fidani dr. m. luisetto 2012 All right reserved , acce...
Richiesta al miur dr. m.fidani dr. m. luisetto 2012 All right reserved , acce...Richiesta al miur dr. m.fidani dr. m. luisetto 2012 All right reserved , acce...
Richiesta al miur dr. m.fidani dr. m. luisetto 2012 All right reserved , acce...
 
Clinical audit may 2011 nes pharmacy
Clinical audit  may 2011 nes pharmacyClinical audit  may 2011 nes pharmacy
Clinical audit may 2011 nes pharmacy
 
Legislation and regulation for best practices in pharmacy ra psn
Legislation and regulation for best practices in pharmacy ra psnLegislation and regulation for best practices in pharmacy ra psn
Legislation and regulation for best practices in pharmacy ra psn
 
Food control agency and their roles
Food control agency and their rolesFood control agency and their roles
Food control agency and their roles
 

Ähnlich wie Encouraging best practice and improve the rational use of medicines

Community Pharmacy Practice.pptx
Community Pharmacy Practice.pptxCommunity Pharmacy Practice.pptx
Community Pharmacy Practice.pptxAjitKumar428826
 
Non medical prescribing - Bridget Crofts
Non medical prescribing - Bridget CroftsNon medical prescribing - Bridget Crofts
Non medical prescribing - Bridget CroftsSHUAHP
 
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfPMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfMuungoLungwani
 
hod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptxhod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptxGeletaGalataa
 
Implementing and Evaluating the Hospital Guide to Reducing Medicaid Readmissions
Implementing and Evaluating the Hospital Guide to Reducing Medicaid ReadmissionsImplementing and Evaluating the Hospital Guide to Reducing Medicaid Readmissions
Implementing and Evaluating the Hospital Guide to Reducing Medicaid ReadmissionsJSI
 
Patient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptxPatient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptxDrVivekChauhan1
 
Final eHO EMR Benefits Report Jan2013
Final eHO EMR Benefits Report Jan2013Final eHO EMR Benefits Report Jan2013
Final eHO EMR Benefits Report Jan2013Emmanuel Casalino
 
PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEERamesh Ganpisetti
 
hod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptxhod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptxRavi Birhman
 
Who strategyon researchforhealth_jan09
Who strategyon researchforhealth_jan09Who strategyon researchforhealth_jan09
Who strategyon researchforhealth_jan09Kizito Lubano
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluationVeena Suresh
 
The use of guidelines and clinical pathways
The use of guidelines and clinical pathwaysThe use of guidelines and clinical pathways
The use of guidelines and clinical pathwaysJoven Botin Bilbao
 
Presentation: IGDRP - Mission, scope, how it works
Presentation: IGDRP - Mission, scope, how it worksPresentation: IGDRP - Mission, scope, how it works
Presentation: IGDRP - Mission, scope, how it worksTGA Australia
 
Recommendations for Improving_Diagnosis
Recommendations for Improving_DiagnosisRecommendations for Improving_Diagnosis
Recommendations for Improving_DiagnosisEngagingPatients
 
Drug utilisation evaluation
Drug utilisation evaluation Drug utilisation evaluation
Drug utilisation evaluation Irene Vadakkan
 

Ähnlich wie Encouraging best practice and improve the rational use of medicines (20)

Community Pharmacy Practice.pptx
Community Pharmacy Practice.pptxCommunity Pharmacy Practice.pptx
Community Pharmacy Practice.pptx
 
Drug utilisation review
 Drug utilisation review  Drug utilisation review
Drug utilisation review
 
Non medical prescribing - Bridget Crofts
Non medical prescribing - Bridget CroftsNon medical prescribing - Bridget Crofts
Non medical prescribing - Bridget Crofts
 
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfPMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
 
hod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptxhod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptx
 
Implementing and Evaluating the Hospital Guide to Reducing Medicaid Readmissions
Implementing and Evaluating the Hospital Guide to Reducing Medicaid ReadmissionsImplementing and Evaluating the Hospital Guide to Reducing Medicaid Readmissions
Implementing and Evaluating the Hospital Guide to Reducing Medicaid Readmissions
 
Patient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptxPatient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptx
 
Final eHO EMR Benefits Report Jan2013
Final eHO EMR Benefits Report Jan2013Final eHO EMR Benefits Report Jan2013
Final eHO EMR Benefits Report Jan2013
 
PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEE
 
hod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptxhod-policies-slide-set-pptx.pptx
hod-policies-slide-set-pptx.pptx
 
Health system development2
Health system development2Health system development2
Health system development2
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
 
CPG ADAPTATION METHODOLOGY
CPG ADAPTATION METHODOLOGYCPG ADAPTATION METHODOLOGY
CPG ADAPTATION METHODOLOGY
 
Who strategyon researchforhealth_jan09
Who strategyon researchforhealth_jan09Who strategyon researchforhealth_jan09
Who strategyon researchforhealth_jan09
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
 
Medical Documentation
Medical DocumentationMedical Documentation
Medical Documentation
 
The use of guidelines and clinical pathways
The use of guidelines and clinical pathwaysThe use of guidelines and clinical pathways
The use of guidelines and clinical pathways
 
Presentation: IGDRP - Mission, scope, how it works
Presentation: IGDRP - Mission, scope, how it worksPresentation: IGDRP - Mission, scope, how it works
Presentation: IGDRP - Mission, scope, how it works
 
Recommendations for Improving_Diagnosis
Recommendations for Improving_DiagnosisRecommendations for Improving_Diagnosis
Recommendations for Improving_Diagnosis
 
Drug utilisation evaluation
Drug utilisation evaluation Drug utilisation evaluation
Drug utilisation evaluation
 

Mehr von MeTApresents

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reportingMeTApresents
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The PhilippinesMeTApresents
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTApresents
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And MilestonesMeTApresents
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core PrinciplesMeTApresents
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosureMeTApresents
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTApresents
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in ZambiaMeTApresents
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTApresents
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTApresents
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTApresents
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processesMeTApresents
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in JordanMeTApresents
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestonesMeTApresents
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTApresents
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in GhanaMeTApresents
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanMeTApresents
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and futureMeTApresents
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance noteMeTApresents
 

Mehr von MeTApresents (20)

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The Philippines
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
 
MeTA introduction
MeTA introductionMeTA introduction
MeTA introduction
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core Principles
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosure
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in Zambia
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in Zambia
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in Uganda
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reporting
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendations
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in Jordan
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestones
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in Ghana
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein Kyrgyzstan
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and future
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance note
 

Kürzlich hochgeladen

Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerSherrylee83
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenRaju678948
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSachin Sharma
 
Get the best psychology treatment in Indore at Gokuldas Hospital
Get the best psychology treatment in Indore at Gokuldas HospitalGet the best psychology treatment in Indore at Gokuldas Hospital
Get the best psychology treatment in Indore at Gokuldas HospitalGokuldas Hospital
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Anjali Parmar
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas HospitalVaricose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas HospitalGokuldas Hospital
 
Tissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood BankingTissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood BankingDrShinyKajal
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةMohamad محمد Al-Gailani الكيلاني
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...ocean4396
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...bkling
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Health Kinesiology Natural Bioenergetics
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?DrShinyKajal
 

Kürzlich hochgeladen (20)

Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 
Get the best psychology treatment in Indore at Gokuldas Hospital
Get the best psychology treatment in Indore at Gokuldas HospitalGet the best psychology treatment in Indore at Gokuldas Hospital
Get the best psychology treatment in Indore at Gokuldas Hospital
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - Subconscious
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas HospitalVaricose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
 
Tissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood BankingTissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood Banking
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
 

Encouraging best practice and improve the rational use of medicines

  • 1. Pharmacist Lama Al.Homoud Director of Clinical Pharmacy Directorate / MOH MeTA Committee 1: Encouraging best practice & Improve Rational Use of Medicines
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.

Hinweis der Redaktion

  1. Title of presentation 10/06/09 MeTA